4th Quarter - Report

FABIANI & COMPANY for OCERA THERAPEUTICS INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Funding for biopharmaceutical product development with DOD to address nuclear warfare threats and treat long term health impact of chronic substance abuse.

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
MELISSA DUPREE —
JAMES P FABIANI —
ERIN FRY —
MARTIN GREEN —
DANIELLE ORGAN PETERS —
WENDY SHELTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Funding for biopharmaceutical product development with DOD to address nuclear warfare threats and treat long term health impact of chronic substance abuse.

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
MELISSA DUPREE —
JAMES P FABIANI —
ERIN FRY —
MARTIN GREEN —
DANIELLE ORGAN PETERS —
WENDY SHELTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.